Journal of Biological Chemistry, ISSN 0021-9258, 08/2012, Volume 287, Issue 35, pp. 30024 - 30034
O-linked-N-acetyl-glucosamine glycosylation (O-GlcNAcylation) of the serine and threonine residues of cellular proteins is a dynamic process and affects...
CROSS-TALK | FUSION | GLCNACYLATION | PHOSPHORYLATION | REGULATES MITOCHONDRIAL FISSION | GLUCOSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | MAMMALIAN-CELLS | MASS-SPECTROMETRY | MORPHOLOGY | Mitochondrial Diseases - pathology | Dynamins - metabolism | Mitochondria, Heart - metabolism | Mitochondria, Heart - pathology | Humans | Diabetes Mellitus, Experimental - genetics | Mitochondrial Diseases - metabolism | Cytoplasm - metabolism | Acetylglucosaminidase - genetics | Cytoplasm - pathology | Acetylglucosamine - metabolism | Phosphorylation - genetics | Acetylglucosaminidase - metabolism | Muscle Proteins - metabolism | Membrane Potential, Mitochondrial - genetics | Cytoplasm - genetics | Diabetes Complications - genetics | Acetylation | Diabetes Complications - pathology | Diabetes Mellitus, Experimental - metabolism | Mitochondria, Heart - genetics | Mitochondrial Diseases - genetics | Diabetes Complications - metabolism | Dynamins - genetics | Acetylglucosamine - genetics | Protein Transport - genetics | Muscle Proteins - genetics | Myocytes, Cardiac - pathology | Animals | Diabetes Mellitus, Experimental - pathology | Myocytes, Cardiac - metabolism | Mice | O-GlcNAcylation | Mitochondria | Glycosylation | Diabetes | Cardiomyopathy | Cell Biology
CROSS-TALK | FUSION | GLCNACYLATION | PHOSPHORYLATION | REGULATES MITOCHONDRIAL FISSION | GLUCOSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | MAMMALIAN-CELLS | MASS-SPECTROMETRY | MORPHOLOGY | Mitochondrial Diseases - pathology | Dynamins - metabolism | Mitochondria, Heart - metabolism | Mitochondria, Heart - pathology | Humans | Diabetes Mellitus, Experimental - genetics | Mitochondrial Diseases - metabolism | Cytoplasm - metabolism | Acetylglucosaminidase - genetics | Cytoplasm - pathology | Acetylglucosamine - metabolism | Phosphorylation - genetics | Acetylglucosaminidase - metabolism | Muscle Proteins - metabolism | Membrane Potential, Mitochondrial - genetics | Cytoplasm - genetics | Diabetes Complications - genetics | Acetylation | Diabetes Complications - pathology | Diabetes Mellitus, Experimental - metabolism | Mitochondria, Heart - genetics | Mitochondrial Diseases - genetics | Diabetes Complications - metabolism | Dynamins - genetics | Acetylglucosamine - genetics | Protein Transport - genetics | Muscle Proteins - genetics | Myocytes, Cardiac - pathology | Animals | Diabetes Mellitus, Experimental - pathology | Myocytes, Cardiac - metabolism | Mice | O-GlcNAcylation | Mitochondria | Glycosylation | Diabetes | Cardiomyopathy | Cell Biology
Journal Article
British Journal of Cancer, ISSN 0007-0920, 07/2018, Volume 119, Issue 2, pp. 230 - 240
BACKGROUND: Fusion genes are good candidates of molecular targets for cancer therapy. However, there is insufficient research on the clinical implications and...
CELL LUNG-CANCER | COLON-CANCER | DOMAIN | PROTEIN | ONCOLOGY | FOLATE RECEPTOR-BETA | CATENIN | POTENTIAL THERAPEUTIC TARGET | ALK FUSION | EXPRESSION | BREAST | Calmodulin-Binding Proteins - genetics | Cell Proliferation - genetics | Folate Receptor 2 - genetics | Membrane Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Transcription Factor TFIIIA - genetics | Male | Acetylglucosaminidase - genetics | Nerve Tissue Proteins - genetics | Cell Movement - genetics | Anaplastic Lymphoma Kinase - genetics | Ikaros Transcription Factor - genetics | Disease-Free Survival | Colorectal Neoplasms - therapy | Oncogene Proteins, Fusion - genetics | Cyclin-Dependent Kinase 8 - genetics | Female | High-Throughput Nucleotide Sequencing | Colorectal Neoplasms - pathology | Gene Expression Regulation, Neoplastic - genetics | Precision Medicine | Cell proliferation | Genes | Colorectal carcinoma | Colorectal cancer | Data processing | Ribonucleic acid--RNA | Gene expression | Cell fusion | Patients | Gene fusion | Molecular chains | Gene sequencing | Cell lines | Mutation | Cell migration | Tumors | Cancer
CELL LUNG-CANCER | COLON-CANCER | DOMAIN | PROTEIN | ONCOLOGY | FOLATE RECEPTOR-BETA | CATENIN | POTENTIAL THERAPEUTIC TARGET | ALK FUSION | EXPRESSION | BREAST | Calmodulin-Binding Proteins - genetics | Cell Proliferation - genetics | Folate Receptor 2 - genetics | Membrane Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Transcription Factor TFIIIA - genetics | Male | Acetylglucosaminidase - genetics | Nerve Tissue Proteins - genetics | Cell Movement - genetics | Anaplastic Lymphoma Kinase - genetics | Ikaros Transcription Factor - genetics | Disease-Free Survival | Colorectal Neoplasms - therapy | Oncogene Proteins, Fusion - genetics | Cyclin-Dependent Kinase 8 - genetics | Female | High-Throughput Nucleotide Sequencing | Colorectal Neoplasms - pathology | Gene Expression Regulation, Neoplastic - genetics | Precision Medicine | Cell proliferation | Genes | Colorectal carcinoma | Colorectal cancer | Data processing | Ribonucleic acid--RNA | Gene expression | Cell fusion | Patients | Gene fusion | Molecular chains | Gene sequencing | Cell lines | Mutation | Cell migration | Tumors | Cancer
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 1/2017, Volume 68, Issue 1, pp. 445 - 458
Several proteins that are mutated in lysosomal storage diseases are linked to neurodegenerative disease. This review focuses on some of these lysosomal enzymes...
neurodegenerative disease | Parkinson's disease | lysosomal storage disease | neurodegenerative drug candidates | Neurodegenerative disease | Lysosomal storage disease | Neurodegenerative drug candidates | MEDICINE, RESEARCH & EXPERIMENTAL | UBIQUITIN-PROTEASOME SYSTEM | STORAGE DISEASES | PHARMACOLOGICAL CHAPERONES | GLUCOCEREBROSIDASE MUTATIONS | NIEMANN-PICK C1 | AMYLOID-BETA PEPTIDE | RISK-FACTOR | ALPHA-SYNUCLEIN ACCUMULATION | NEURONOPATHIC GAUCHER-DISEASE | PARKINSONS-DISEASE | Sphingomyelin Phosphodiesterase - genetics | Glucosylceramidase - genetics | Humans | Lysosomal Storage Diseases - genetics | Lysosomes - enzymology | Neurodegenerative Diseases - genetics | Acetylglucosaminidase - genetics | Autophagy | Membrane Glycoproteins - genetics | Proteins - genetics | Carrier Proteins - genetics | Amyloidogenic Proteins - metabolism | Endocytosis | Hexosaminidase B - genetics | Proteins - metabolism | Proton-Translocating ATPases - genetics | Lysosomal Storage Diseases - drug therapy | Lysosomal Storage Diseases - metabolism | Lysosomal Storage Diseases - complications | Hexosaminidase A - genetics | Metabolism, Inborn errors of | Complications and side effects | Care and treatment | Nervous system | Genetic aspects | Degeneration | Risk factors
neurodegenerative disease | Parkinson's disease | lysosomal storage disease | neurodegenerative drug candidates | Neurodegenerative disease | Lysosomal storage disease | Neurodegenerative drug candidates | MEDICINE, RESEARCH & EXPERIMENTAL | UBIQUITIN-PROTEASOME SYSTEM | STORAGE DISEASES | PHARMACOLOGICAL CHAPERONES | GLUCOCEREBROSIDASE MUTATIONS | NIEMANN-PICK C1 | AMYLOID-BETA PEPTIDE | RISK-FACTOR | ALPHA-SYNUCLEIN ACCUMULATION | NEURONOPATHIC GAUCHER-DISEASE | PARKINSONS-DISEASE | Sphingomyelin Phosphodiesterase - genetics | Glucosylceramidase - genetics | Humans | Lysosomal Storage Diseases - genetics | Lysosomes - enzymology | Neurodegenerative Diseases - genetics | Acetylglucosaminidase - genetics | Autophagy | Membrane Glycoproteins - genetics | Proteins - genetics | Carrier Proteins - genetics | Amyloidogenic Proteins - metabolism | Endocytosis | Hexosaminidase B - genetics | Proteins - metabolism | Proton-Translocating ATPases - genetics | Lysosomal Storage Diseases - drug therapy | Lysosomal Storage Diseases - metabolism | Lysosomal Storage Diseases - complications | Hexosaminidase A - genetics | Metabolism, Inborn errors of | Complications and side effects | Care and treatment | Nervous system | Genetic aspects | Degeneration | Risk factors
Journal Article
Biochemistry, ISSN 0006-2960, 06/2011, Volume 50, Issue 25, pp. 5693 - 5703
Enzymatic features that determine transglycosylating activity have been investigated through site-directed mutagenesis studies on two family 18 chitinases,...
CHITOOLIGOSACCHARIDES | BETA-N-ACETYLGLUCOSAMINIDASE | ACIDIC MAMMALIAN CHITINASE | OLIGOSACCHARIDES | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING CLEFT | RESOLUTION | SERRATIA-MARCESCENS | AROMATIC RESIDUES | TRICHODERMA-HARZIANUM | Multigene Family - genetics | Mutagenesis, Site-Directed | Bacterial Proteins - chemical synthesis | Bacterial Proteins - genetics | Catalytic Domain - genetics | Glycosylation | Chitinases - chemical synthesis | Substrate Specificity - genetics | Chitinases - genetics | Aspartic Acid - genetics | Chitinases - classification | Hydrolysis | Point Mutation | Serratia marcescens - genetics | Oligosaccharides - chemistry | Serratia marcescens - enzymology | Enzyme Stability - genetics | Asparagine - genetics | Oligosaccharides - genetics | Chemical mutagenesis | Usage | Analysis | Digestive enzymes | Genetic aspects | Chemical properties | Mass spectrometry | Methods | Nocardia corallina | Index Medicus
CHITOOLIGOSACCHARIDES | BETA-N-ACETYLGLUCOSAMINIDASE | ACIDIC MAMMALIAN CHITINASE | OLIGOSACCHARIDES | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING CLEFT | RESOLUTION | SERRATIA-MARCESCENS | AROMATIC RESIDUES | TRICHODERMA-HARZIANUM | Multigene Family - genetics | Mutagenesis, Site-Directed | Bacterial Proteins - chemical synthesis | Bacterial Proteins - genetics | Catalytic Domain - genetics | Glycosylation | Chitinases - chemical synthesis | Substrate Specificity - genetics | Chitinases - genetics | Aspartic Acid - genetics | Chitinases - classification | Hydrolysis | Point Mutation | Serratia marcescens - genetics | Oligosaccharides - chemistry | Serratia marcescens - enzymology | Enzyme Stability - genetics | Asparagine - genetics | Oligosaccharides - genetics | Chemical mutagenesis | Usage | Analysis | Digestive enzymes | Genetic aspects | Chemical properties | Mass spectrometry | Methods | Nocardia corallina | Index Medicus
Journal Article
Critical Reviews in Microbiology, ISSN 1040-841X, 8/2015, Volume 41, Issue 3, pp. 341 - 352
Abstract The significance of extracellular DNA (eDNA) in biofilms was overlooked until researchers added DNAse to a Pseudomonas aeruginosa biofilm and watched...
extracellular DNA | Antimicrobial resistance | bacterial adhesion | biofilm | Biofilm | Bacterial adhesion | Extracellular DNA | NATURAL TRANSFORMATION | N-ACETYLGLUCOSAMINIDASE | MICROBIOLOGY | EDNA RELEASE | CHROMOSOMAL DNA | CELL-DEATH | STREPTOCOCCUS-PNEUMONIAE | PSEUDOMONAS-AERUGINOSA | NEISSERIA-GONORRHOEAE | STAPHYLOCOCCUS-AUREUS | HORIZONTAL GENE-TRANSFER | Bacteria - growth & development | Bacteria - immunology | DNA, Bacterial - genetics | Biofilms - growth & development | Immune Evasion - genetics | Bacterial Adhesion - genetics | Drug Resistance, Bacterial - genetics | Bacteria - genetics | Bacterial Physiological Phenomena - genetics | Immune Evasion - immunology | Gene Transfer, Horizontal - genetics | DNA, Bacterial - secretion
extracellular DNA | Antimicrobial resistance | bacterial adhesion | biofilm | Biofilm | Bacterial adhesion | Extracellular DNA | NATURAL TRANSFORMATION | N-ACETYLGLUCOSAMINIDASE | MICROBIOLOGY | EDNA RELEASE | CHROMOSOMAL DNA | CELL-DEATH | STREPTOCOCCUS-PNEUMONIAE | PSEUDOMONAS-AERUGINOSA | NEISSERIA-GONORRHOEAE | STAPHYLOCOCCUS-AUREUS | HORIZONTAL GENE-TRANSFER | Bacteria - growth & development | Bacteria - immunology | DNA, Bacterial - genetics | Biofilms - growth & development | Immune Evasion - genetics | Bacterial Adhesion - genetics | Drug Resistance, Bacterial - genetics | Bacteria - genetics | Bacterial Physiological Phenomena - genetics | Immune Evasion - immunology | Gene Transfer, Horizontal - genetics | DNA, Bacterial - secretion
Journal Article
Journal of Inherited Metabolic Disease, ISSN 0141-8955, 3/2013, Volume 36, Issue 2, pp. 179 - 187
Mucopolysaccharidosis (MPS) disorders are heterogeneous and caused by deficient lysosomal degradation of glycosaminoglycans, resulting in distinct but...
Human Genetics | Biochemistry, general | Pediatrics | Internal Medicine | Medicine & Public Health | Metabolic Diseases | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | GLYCOSAMINOGLYCANS | FLUOROMETRIC ENZYME ASSAY | TANDEM MASS-SPECTROMETRY | SANFILIPPO | SCREENING NEWBORNS | BLOOD SPOTS APPLICATION | HUNTER-SYNDROME | IVA | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | LYSOSOMAL-ENZYMES | Chondroitinsulfatases - genetics | Hydrolases - genetics | Exons | Mucopolysaccharidoses - enzymology | Gene Frequency | Humans | Acetylglucosaminidase - genetics | N-Acetylgalactosamine-4-Sulfatase - genetics | DNA Mutational Analysis | Iduronate Sulfatase - genetics | Mucopolysaccharidoses - genetics | Mutation | Iduronidase - genetics | Cohort Studies | Glycosaminoglycans | Invisibility | Analysis | Genes | Mucopolysaccharidosis | Genetic aspects | Population genetics
Human Genetics | Biochemistry, general | Pediatrics | Internal Medicine | Medicine & Public Health | Metabolic Diseases | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | GLYCOSAMINOGLYCANS | FLUOROMETRIC ENZYME ASSAY | TANDEM MASS-SPECTROMETRY | SANFILIPPO | SCREENING NEWBORNS | BLOOD SPOTS APPLICATION | HUNTER-SYNDROME | IVA | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | LYSOSOMAL-ENZYMES | Chondroitinsulfatases - genetics | Hydrolases - genetics | Exons | Mucopolysaccharidoses - enzymology | Gene Frequency | Humans | Acetylglucosaminidase - genetics | N-Acetylgalactosamine-4-Sulfatase - genetics | DNA Mutational Analysis | Iduronate Sulfatase - genetics | Mucopolysaccharidoses - genetics | Mutation | Iduronidase - genetics | Cohort Studies | Glycosaminoglycans | Invisibility | Analysis | Genes | Mucopolysaccharidosis | Genetic aspects | Population genetics
Journal Article
Biochemical Journal, ISSN 0264-6021, 03/2014, Volume 458, Issue 2, pp. 281 - 289
Enzyme replacement therapy for MPS IIIB (mucopolysaccharidosis type IIIB; also known as Sanfilippo B syndrome) has been hindered by inadequate mannose 6...
Mucopolysaccharidosis | Lysosomal storage disease | Enzyme replacement therapy | Sanfilippo | Insulin-like growth factor (IGF) | enzyme replacement therapy | NEUROLOGICAL DISEASE | GENE DELIVERY | lysosomal storage disease | SANFILIPPO-SYNDROME | BIOCHEMISTRY & MOLECULAR BIOLOGY | mucopolysaccharidosis | SYNDROME TYPE-B | CEREBROSPINAL-FLUID | ENZYME-REPLACEMENT THERAPY | MURINE MODEL | insulin-like growth factor (IGF) | HAMSTER OVARY CELLS | MOUSE MODEL | CENTRAL-NERVOUS-SYSTEM | Fibroblasts - enzymology | Protein Binding - genetics | Cricetulus | Humans | Lysosomes - genetics | Lysosomes - enzymology | Acetylglucosaminidase - genetics | Recombinant Fusion Proteins - metabolism | Insulin-Like Growth Factor II - genetics | Lysosomes - metabolism | Acetylglucosaminidase - metabolism | Mucopolysaccharidosis III - metabolism | Endocytosis - genetics | Acetylglucosaminidase - biosynthesis | CHO Cells | Fibroblasts - metabolism | Cricetinae | Mucopolysaccharidosis III - genetics | Up-Regulation - genetics | Binding Sites - genetics | Fibroblasts - pathology | Mucopolysaccharidosis III - enzymology | Animals | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Amino Acid Motifs - genetics | insulin-like growth factor
Mucopolysaccharidosis | Lysosomal storage disease | Enzyme replacement therapy | Sanfilippo | Insulin-like growth factor (IGF) | enzyme replacement therapy | NEUROLOGICAL DISEASE | GENE DELIVERY | lysosomal storage disease | SANFILIPPO-SYNDROME | BIOCHEMISTRY & MOLECULAR BIOLOGY | mucopolysaccharidosis | SYNDROME TYPE-B | CEREBROSPINAL-FLUID | ENZYME-REPLACEMENT THERAPY | MURINE MODEL | insulin-like growth factor (IGF) | HAMSTER OVARY CELLS | MOUSE MODEL | CENTRAL-NERVOUS-SYSTEM | Fibroblasts - enzymology | Protein Binding - genetics | Cricetulus | Humans | Lysosomes - genetics | Lysosomes - enzymology | Acetylglucosaminidase - genetics | Recombinant Fusion Proteins - metabolism | Insulin-Like Growth Factor II - genetics | Lysosomes - metabolism | Acetylglucosaminidase - metabolism | Mucopolysaccharidosis III - metabolism | Endocytosis - genetics | Acetylglucosaminidase - biosynthesis | CHO Cells | Fibroblasts - metabolism | Cricetinae | Mucopolysaccharidosis III - genetics | Up-Regulation - genetics | Binding Sites - genetics | Fibroblasts - pathology | Mucopolysaccharidosis III - enzymology | Animals | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Amino Acid Motifs - genetics | insulin-like growth factor
Journal Article
Molecular Therapy, ISSN 1525-0016, 06/2011, Volume 19, Issue 6, pp. 1025 - 1033
The greatest challenge in developing therapies for mucopolysaccharidosis (MPS) IIIB is to achieve efficient central nervous system (CNS) delivery across the...
MEDICINE, RESEARCH & EXPERIMENTAL | AAV VECTORS | LYSOSOMAL STORAGE DISEASE | NEUTRALIZING ANTIBODIES | ADENOASSOCIATED VIRUS | SYNDROME TYPE-B | FUNCTIONAL CORRECTION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IMMUNE-RESPONSES | MOUSE MODEL | GENETICS & HEREDITY | MPS IIIB | ALPHA-N-ACETYLGLUCOSAMINIDASE | Dependovirus - genetics | Animals | Acetylglucosaminidase - metabolism | Mucopolysaccharidosis III - therapy | Polymerase Chain Reaction | Mice | Acetylglucosaminidase - genetics | Genetic Vectors - genetics | Blood-Brain Barrier - metabolism | Genetic Therapy - methods | Mice, Knockout | Nervous System Diseases - therapy | Original
MEDICINE, RESEARCH & EXPERIMENTAL | AAV VECTORS | LYSOSOMAL STORAGE DISEASE | NEUTRALIZING ANTIBODIES | ADENOASSOCIATED VIRUS | SYNDROME TYPE-B | FUNCTIONAL CORRECTION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IMMUNE-RESPONSES | MOUSE MODEL | GENETICS & HEREDITY | MPS IIIB | ALPHA-N-ACETYLGLUCOSAMINIDASE | Dependovirus - genetics | Animals | Acetylglucosaminidase - metabolism | Mucopolysaccharidosis III - therapy | Polymerase Chain Reaction | Mice | Acetylglucosaminidase - genetics | Genetic Vectors - genetics | Blood-Brain Barrier - metabolism | Genetic Therapy - methods | Mice, Knockout | Nervous System Diseases - therapy | Original
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 2017, Volume 925, pp. 41 - 56
The flagellum is an important macromolecular machine for many pathogenic bacteria. It is a hetero-oligomeric structure comprised of three major sub-structures:...
Peptidoglycan | β-N-acetylglucosaminidases | Flagella | Lytic transglycosylases | Peptidoglycan - metabolism | Multigene Family | Bacterial Proteins - chemistry | Helicobacter pylori - genetics | Flagella - enzymology | Acetylglucosaminidase - genetics | Salmonella typhimurium - ultrastructure | Acetylglucosaminidase - metabolism | Helicobacter pylori - enzymology | Pseudomonas aeruginosa - enzymology | Flagella - genetics | Salmonella typhimurium - enzymology | Amino Acid Sequence | Escherichia coli - enzymology | Peptidoglycan Glycosyltransferase - metabolism | Flagella - ultrastructure | Peptidoglycan Glycosyltransferase - chemistry | Salmonella typhimurium - genetics | Bacterial Proteins - genetics | Helicobacter pylori - ultrastructure | Bacteriolysis - genetics | Peptidoglycan Glycosyltransferase - genetics | Sequence Alignment | Pseudomonas aeruginosa - genetics | Escherichia coli - genetics | Acetylglucosaminidase - chemistry | Bacterial Proteins - metabolism | Gene Expression Regulation, Bacterial | Pseudomonas aeruginosa - ultrastructure | Escherichia coli - ultrastructure
Peptidoglycan | β-N-acetylglucosaminidases | Flagella | Lytic transglycosylases | Peptidoglycan - metabolism | Multigene Family | Bacterial Proteins - chemistry | Helicobacter pylori - genetics | Flagella - enzymology | Acetylglucosaminidase - genetics | Salmonella typhimurium - ultrastructure | Acetylglucosaminidase - metabolism | Helicobacter pylori - enzymology | Pseudomonas aeruginosa - enzymology | Flagella - genetics | Salmonella typhimurium - enzymology | Amino Acid Sequence | Escherichia coli - enzymology | Peptidoglycan Glycosyltransferase - metabolism | Flagella - ultrastructure | Peptidoglycan Glycosyltransferase - chemistry | Salmonella typhimurium - genetics | Bacterial Proteins - genetics | Helicobacter pylori - ultrastructure | Bacteriolysis - genetics | Peptidoglycan Glycosyltransferase - genetics | Sequence Alignment | Pseudomonas aeruginosa - genetics | Escherichia coli - genetics | Acetylglucosaminidase - chemistry | Bacterial Proteins - metabolism | Gene Expression Regulation, Bacterial | Pseudomonas aeruginosa - ultrastructure | Escherichia coli - ultrastructure
Journal Article
Journal of Inherited Metabolic Disease, ISSN 0141-8955, 2008, Volume 31, Issue 2, pp. 240 - 252
Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is an autosomal recessive disorder, caused by a deficiency in one of the four enzymes involved in...
Biochemistry, general | Human Genetics | Pediatrics | Internal Medicine | Medicine & Public Health | Metabolic Diseases | MUCOPOLYSACCHARIDOSIS TYPE IIIA | BONE-MARROW-TRANSPLANTATION | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | SYNDROME TYPE-B | SYNDROME TYPE-A | LYSOSOMAL STORAGE DISEASES | FLUOROMETRIC ENZYME ASSAY | MANNOSE 6-PHOSPHATE RECEPTOR | BLOOD-BRAIN-BARRIER | ALPHA-N-ACETYLGLUCOSAMINIDASE | SUBSTRATE DEPRIVATION THERAPY | Sulfatases - genetics | Hydrolases - genetics | Prognosis | Humans | Child, Preschool | Lysosomes - enzymology | Infant | Acetylglucosaminidase - genetics | Acetyltransferases - genetics | Heparitin Sulfate - metabolism | Incidence | Young Adult | Mucopolysaccharidosis III - diagnosis | Mucopolysaccharidosis III - mortality | Acetyltransferases - deficiency | Time Factors | Adult | Child | Acetylglucosaminidase - deficiency | Genetic Predisposition to Disease | Mucopolysaccharidosis III - genetics | Sulfatases - deficiency | Hydrolases - deficiency | Mucopolysaccharidosis III - enzymology | Phenotype | Animals | Adolescent | Mucopolysaccharidosis III - therapy
Biochemistry, general | Human Genetics | Pediatrics | Internal Medicine | Medicine & Public Health | Metabolic Diseases | MUCOPOLYSACCHARIDOSIS TYPE IIIA | BONE-MARROW-TRANSPLANTATION | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | SYNDROME TYPE-B | SYNDROME TYPE-A | LYSOSOMAL STORAGE DISEASES | FLUOROMETRIC ENZYME ASSAY | MANNOSE 6-PHOSPHATE RECEPTOR | BLOOD-BRAIN-BARRIER | ALPHA-N-ACETYLGLUCOSAMINIDASE | SUBSTRATE DEPRIVATION THERAPY | Sulfatases - genetics | Hydrolases - genetics | Prognosis | Humans | Child, Preschool | Lysosomes - enzymology | Infant | Acetylglucosaminidase - genetics | Acetyltransferases - genetics | Heparitin Sulfate - metabolism | Incidence | Young Adult | Mucopolysaccharidosis III - diagnosis | Mucopolysaccharidosis III - mortality | Acetyltransferases - deficiency | Time Factors | Adult | Child | Acetylglucosaminidase - deficiency | Genetic Predisposition to Disease | Mucopolysaccharidosis III - genetics | Sulfatases - deficiency | Hydrolases - deficiency | Mucopolysaccharidosis III - enzymology | Phenotype | Animals | Adolescent | Mucopolysaccharidosis III - therapy
Journal Article